semaglutide cause bone loss Effects of Glucagon-Like Peptide-1 receptor agonists on health in people living with obesity Comparative safety and side effects

Today, Im down to a super-toned 160 poundsa weight Ive maintained for two years, and I feel absolutely amazing

Liu X, Ma Q, Jia Z, Zhou Y, Zou C, Xiao Y, et al

Lyophilization precision freeze-drying removes water under vacuum so the molecule can be stored at room temperature or frozen until reconstitution

It highlights a potential new therapeutic avenue for patients with obesity-associated asthma. In a real-world retrospective cohort study, Patel and colleagues at Drexel University College of Medicine assessed patients from the TriNetX global collaborative network without diabetes but with asthma belonging to one of three weight classes overweight (BMI 25 kg/m 2 -29.99 kg/m 2 ), obese (BMI 30 kg/m 2 -40 kg/m 2 ) or morbidly obese (BMI at least 40 kg/m 2 ) to determine the impact of GLP-1 receptor agonist treatment on the risk for asthma exacerbation

It explains why two patients taking similar medications may have entirely different treatment journeys, and why the expansion of GLP-1 use has created both opportunities and tensions within healthcare systems